Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alkindo Naratama Tbk (ALDO) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Alkindo Naratama TbkTrade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Alkindo Naratama Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Alkindo Naratama Tbk trades at Rp870 (market cap 2.4T, 103.8K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 5.2× Alkindo Naratama Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (235.2K versus 103.8K). Which is the better fit depends on your goals.

ALDOTSPC
Market Cap
2.4T12.58T
Volume
103.8K235.2K
Lot
1.04K2.35K
Turnover
90.11M649.94M
Average Price
868.162,763.37
Value
90.11M649.94M
Indicative Equilibrium Price
8702,780
Indicative Equilibrium Volume
109

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ALDO
View details
TSPC
View details

About Alkindo Naratama Tbk

PT Alkindo Naratama Tbk (the "Company") was established based on Notarial Deed No 74 of Kikit Warianti SH, dated January 31, 1989. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 5 of Nunuy Rahmayati SH dated March 15, 2011 pertaining of Authorized share and paid-up capital, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity

Read more on ALDO

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC